VERO icon

Venus Concept

0.3227 USD
+0.0058
1.83%
At close Dec 20, 4:00 PM EST
After hours
0.3025
-0.0202
6.26%
1 day
1.83%
5 days
-7.98%
1 month
6.50%
3 months
-60.97%
6 months
-63.04%
Year to date
-71.44%
1 year
-65.15%
5 years
-99.54%
10 years
-99.78%
 

About: Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Employees: 304

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

4.74% less ownership

Funds ownership: 29.7% [Q2] → 24.96% (-4.74%) [Q3]

19% less funds holding

Funds holding: 16 [Q2] → 13 (-3) [Q3]

25% less capital invested

Capital invested by funds: $1.48M [Q2] → $1.11M (-$372K) [Q3]

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Research analyst outlook

We haven’t received any recent analyst ratings for VERO.

Financial journalist opinion

Neutral
Seeking Alpha
1 month ago
Venus Concept Inc. (VERO) Q3 2024 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO ) Q3 2024 Earnings Conference Call November 13, 2024 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Operating Officer Domenic Della Penna - Executive Vice President and Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Sam Eiber - BTIG Thomas McGovern - Maxim Group Operator Please standby. Good day, ladies and gentlemen, and welcome to the Third Quarter 2024 Earnings Conference Call for Venus Concept Incorporated.
Venus Concept Inc. (VERO) Q3 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
1 month ago
Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results
TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2024.
Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results
Neutral
GlobeNewsWire
1 month ago
Venus Concept Announces Expansion of International Distribution Network and Certification of Products in India
Enhances future international growth profile with new partners and regulatory certifications in key global aesthetic markets Enhances future international growth profile with new partners and regulatory certifications in key global aesthetic markets
Venus Concept Announces Expansion of International Distribution Network and Certification of Products in India
Neutral
GlobeNewsWire
2 months ago
Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024
TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, November 13, 2024.
Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024
Neutral
GlobeNewsWire
2 months ago
Venus Concept Announces $15 million Debt-to-Equity Exchange Transaction
Second Substantial Reduction of Existing Debt by Madryn Asset Management in 2024; the Company has reduced its debt balance by 54% year-to-date Second Substantial Reduction of Existing Debt by Madryn Asset Management in 2024; the Company has reduced its debt balance by 54% year-to-date
Venus Concept Announces $15 million Debt-to-Equity Exchange Transaction
Positive
Zacks Investment Research
3 months ago
VERO Stock Likely to Get Support From New Regulatory Nod in Australia
The latest approval for Venus Concept in Australia reinforces its position as a global player in the aesthetic technology space.
VERO Stock Likely to Get Support From New Regulatory Nod in Australia
Neutral
GlobeNewsWire
3 months ago
Venus Concept Announces Australian Regulatory Approval for Venus Bliss MAX
TORONTO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has clearance from the Therapeutic Goods Administration (TGA) in Australia to market the Venus Bliss MAX system. The Venus Bliss MAX is the Company's flagship platform that offers a comprehensive, world-class solution for all customers' body treatment needs and is currently available in select markets globally.
Venus Concept Announces Australian Regulatory Approval for Venus Bliss MAX
Neutral
Seeking Alpha
4 months ago
Venus Concept Inc. (VERO) Q2 2024 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO ) Q2 2024 Earnings Conference Call August 13, 2024 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Operating Officer Domenic Della Penna - Executive Vice President and Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Thomas McGovern - Maxim Group Operator Please standby. Good day, ladies and gentlemen, and welcome to the Second Quarter 2024 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode.
Venus Concept Inc. (VERO) Q2 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
4 months ago
Venus Concept Announces Second Quarter of Fiscal Year 2024 Financial Results
TORONTO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2024.
Venus Concept Announces Second Quarter of Fiscal Year 2024 Financial Results
Neutral
GlobeNewsWire
4 months ago
Venus Concept Announces Regulatory Approval for Venus Bliss MAX in Canada
TORONTO, July 29, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medical device license issued by Health Canada to market the Venus Bliss MAX system in Canada. The Venus Bliss MAX was first available in the United States in early 2022 and subsequently offered in approved jurisdictions around the world.
Venus Concept Announces Regulatory Approval for Venus Bliss MAX in Canada
Charts implemented using Lightweight Charts™